Implant Delivers Antiretroviral Drug To Stop Spread Of HIV, Oak Crest Institute Of Science Study

Antiretroviral drugs require patients to adhere to a strict dosing regimen, but as with other diseases patients tend to slack off, often paying a high price. Researchers at the Oak Crest Institute of Science in Pasadena, California have developed a small implant that can deliver tenofovir alafenamide fumarate, a prodrug developed by Gilead Sciences to help treat and prevent HIV infection, in a controlled manner.

Hey, check out all the engineering jobs. Post your resume today!